[Molnupiravir or nirmatrelvir-ritonavir reduce the likelihood of hospitalization and mortality in immunocompromised patients with Covid-19.].
作者信息
Kurotschka Peter K, Ebell Mark H, Serafini Alice
机构信息
Department of General practice, University Hospital Würzburg, Germany.
Department of Epidemiology and biostatistics, the University of Georgia, Athens, Georgia, Usa.
出版信息
Recenti Prog Med. 2024 Sep;115(9):399. doi: 10.1701/4334.43179.
PMID:39269352
Abstract
摘要
Zotero 插件